Compounds > 3'-azido-3'-deoxy-5'-o-beta-glucopyranuronosylthymidine
Page last updated: 2024-08-26

3'-azido-3'-deoxy-5'-o-beta-glucopyranuronosylthymidine and valproic acid

3'-azido-3'-deoxy-5'-o-beta-glucopyranuronosylthymidine has been researched along with valproic acid in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agrawal, KC; Akula, S; George, WJ; Greenspan, DL; Hyslop, NE; Lertora, JJ; Rege, AB1
Akula, SK; Dejace, PM; Dreisbach, AW; Lertora, JJ; Rege, AB1

Trials

1 trial(s) available for 3'-azido-3'-deoxy-5'-o-beta-glucopyranuronosylthymidine and valproic acid

ArticleYear
Pharmacokinetic interaction between zidovudine and valproic acid in patients infected with human immunodeficiency virus.
    Clinical pharmacology and therapeutics, 1994, Volume: 56, Issue:3

    Topics: Adult; Biological Availability; Drug Synergism; Half-Life; HIV Infections; Humans; Linear Models; Male; Middle Aged; Valproic Acid; Zidovudine

1994

Other Studies

1 other study(ies) available for 3'-azido-3'-deoxy-5'-o-beta-glucopyranuronosylthymidine and valproic acid

ArticleYear
Valproic acid increases cerebrospinal fluid zidovudine levels in a patient with AIDS.
    The American journal of the medical sciences, 1997, Volume: 313, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS Dementia Complex; Anticonvulsants; Drug Interactions; Humans; Kinetics; Male; Valproic Acid; Zidovudine

1997